Skip to Main Content

INFORMATION FOR

    Rapid Case Ascertainment Shared Resource

    July 24, 2026

    Working as an agent of the Connecticut Tumor Registry, the Rapid Case Ascertainment (RCA) Shared Resource facilitates population-based studies of cancer for YCC investigators as well as outside investigators.

    Contact

    Rajni Mehta, MPH, Director

    rajni.mehta@yale.edu

      ID
      14354

      Transcript

      • 00:00Hi, everybody. I am Raj
      • 00:02Nimehta. I'm the director of
      • 00:04the rapid case ascertainment
      • 00:06shared resource.
      • 00:08And
      • 00:09next slide, please.
      • 00:11So
      • 00:12the rapid case ascertainment resource
      • 00:14is a little different from
      • 00:16probably what you've heard,
      • 00:17because we we work with
      • 00:20investigators conducting
      • 00:21non therapeutic studies. So you
      • 00:23can think of us as
      • 00:25you can think of the
      • 00:26clinical trials office as the
      • 00:28therapeutic,
      • 00:30resource,
      • 00:31and we are the non
      • 00:32therapeutic. So we support,
      • 00:35cancer center members
      • 00:37in,
      • 00:38in studies that are non
      • 00:39therapeutic for case identification,
      • 00:42study management, patient enrollment, medical
      • 00:45record abstraction,
      • 00:47and specimen collection so they
      • 00:49can accomplish their scientific goals.
      • 00:52Next slide.
      • 00:55So we have been a
      • 00:57YCC shared resource since nineteen
      • 00:59ninety five,
      • 01:01and we wear several different
      • 01:03hats. Right? So we we
      • 01:05work as Yale staff to
      • 01:07support Yale studies, but we
      • 01:09also work,
      • 01:12as agents of the Connecticut
      • 01:13Tumor Registry through a personal
      • 01:15service agreement
      • 01:17so we can collect data
      • 01:18from
      • 01:19outside
      • 01:20hospitals that are not Yale.
      • 01:22So that's kind of our
      • 01:23Connecticut Tumor Registry hat.
      • 01:26So in in this personal
      • 01:28service agreement, after we get
      • 01:30all the approvals,
      • 01:31we can assist investigators
      • 01:34in identifying cases and collecting
      • 01:36specimens from,
      • 01:39Connecticut hospitals for our for
      • 01:41through the Connecticut Tumor Registry.
      • 01:45The cost of RCA
      • 01:47is is really the staff
      • 01:49time and effort. Right? We
      • 01:51we don't have any machines
      • 01:53or we don't have any
      • 01:54equipment. We just charge
      • 01:56for our time and effort
      • 01:59devoted
      • 02:00to what we do for
      • 02:01each investigator,
      • 02:02and we do that in
      • 02:03two ways. So we have
      • 02:04our current,
      • 02:07way of one hundred and
      • 02:08forty dollars an hour, and
      • 02:09that's a fee for service.
      • 02:11And as a cancer center
      • 02:12member,
      • 02:13you get, a fifteen percent,
      • 02:15discount
      • 02:16on that. So it's a
      • 02:17the cancer center pays fifteen
      • 02:19percent of that. So you're
      • 02:20only charged for the eighty,
      • 02:23eighty five percent.
      • 02:25And then another way that
      • 02:27we recover costs is that
      • 02:30some of our staff are
      • 02:31dedicated
      • 02:32to your study
      • 02:34as a percent effort. So
      • 02:36many studies
      • 02:37cannot,
      • 02:38hire a full time person.
      • 02:40So if you can hire
      • 02:41your full time person, great.
      • 02:43You can go and hire
      • 02:44them. But many
      • 02:45of our studies are smaller,
      • 02:47and investigators
      • 02:48only have, like, let's say,
      • 02:49a twenty percent effort or
      • 02:50a ten percent effort. So
      • 02:52that's where we can come
      • 02:53in,
      • 02:54and you can hire somebody
      • 02:56at that
      • 02:57small effort to help you,
      • 02:59and you don't have to
      • 03:00hire somebody because you could
      • 03:02never,
      • 03:03hire somebody at that, level
      • 03:05of effort. So that's how,
      • 03:07some of our staff, you
      • 03:08know, work twenty percent on
      • 03:10one study, twenty percent on
      • 03:11another study. So so it
      • 03:12really helps these smaller
      • 03:14investigators who do not have
      • 03:16a lot of money,
      • 03:17be able to conduct their
      • 03:19studies. Because if if, of
      • 03:21course, if you have a
      • 03:22full time FTE, then it's
      • 03:23great. You have somebody dedicated,
      • 03:25but we can help you
      • 03:26in that way.
      • 03:29In in addition to the
      • 03:31dedicated effort, just being able
      • 03:32to charge you by the
      • 03:33hour is something that some
      • 03:35investigators like because you don't
      • 03:37you only need a certain,
      • 03:39let's say, hundred records extracted.
      • 03:41Right? So we just say,
      • 03:42okay. Can you extract a
      • 03:44hundred records for us? We
      • 03:45don't
      • 03:46it could take us, you
      • 03:47know, a couple of months,
      • 03:48but we just pay you
      • 03:50by the hour that we
      • 03:51work on your study.
      • 03:53So those are the the
      • 03:54two different ways.
      • 03:55Next slide.
      • 03:57And so, again, these are
      • 03:58our key services
      • 04:00that we perform. We have
      • 04:01a lot of experience with
      • 04:03IRB approvals,
      • 04:05overall study management.
      • 04:07You know, people come to
      • 04:08me to say, oh, how
      • 04:09do I get this DUA
      • 04:10done?
      • 04:12Can you help me?
      • 04:13How do I pay sites?
      • 04:15Can you help me pay
      • 04:16sites? And and so these
      • 04:17are just,
      • 04:18staff,
      • 04:19you know, activities that that
      • 04:21people need help with. We
      • 04:23identify
      • 04:24cancer cases. So if you
      • 04:26say
      • 04:27you need to identify everybody
      • 04:29with liver cancer because you
      • 04:30wanna do a study,
      • 04:32and abstract treatment on liver
      • 04:34cancer, so we can help
      • 04:36you with that.
      • 04:37Again, extracting medical records. Many
      • 04:39of our,
      • 04:42you know, the IRB protocols
      • 04:43require physician consent. So we
      • 04:46help investigators
      • 04:47identify the patients and then
      • 04:48contacting these the their their
      • 04:51clinicians for permission to contact
      • 04:53them. We screen them. We
      • 04:55conduct surveys either in person
      • 04:57or,
      • 04:58sending them a link. We
      • 05:00also collect
      • 05:02blood,
      • 05:03specimens during their standard of
      • 05:05care collection. Some some
      • 05:07investigators,
      • 05:10wanna collect an additional tube
      • 05:11of blood
      • 05:12from these, patients that are
      • 05:14getting certain treatments
      • 05:16or,
      • 05:17you know, the COVID vaccine.
      • 05:19They wanna test, you know,
      • 05:21markers, and so we have
      • 05:23done that as well.
      • 05:25Same thing for stool and
      • 05:26CSF.
      • 05:27And we also work with
      • 05:29archival pathology specimens.
      • 05:32We work with Yale New
      • 05:34Haven Hospital with,
      • 05:35the shared resource also, and
      • 05:38we work collecting specimens from
      • 05:40all over the country.
      • 05:43Cohorts, for example, everybody who's
      • 05:45who has,
      • 05:46had, like,
      • 05:48liver cancer,
      • 05:49through the VA, for example.
      • 05:51We've done a study where
      • 05:53we collected from all the
      • 05:54stations at the VA for
      • 05:56patients who had liver cancer.
      • 05:58And then it was brought
      • 05:59you know, they shipped the
      • 06:00specimens. We we worked with
      • 06:02the l pathology
      • 06:03to section them with our
      • 06:04study pathologist,
      • 06:06and then we returned these
      • 06:07specimens.
      • 06:09We also serve as honest
      • 06:11brokers, which means that some
      • 06:13studies that the investigator has
      • 06:15to be blinded.
      • 06:16We're able to be that
      • 06:18person who that the the
      • 06:20the shared resource who knows
      • 06:21who these patients are to
      • 06:23be able to collect the
      • 06:24specimens. But when
      • 06:26we give it to the
      • 06:26investigator, it's de identified.
      • 06:29So the IRBs will usually,
      • 06:32exempt those studies because you're
      • 06:34not collecting any identifiers.
      • 06:36You you we are your
      • 06:38middle person, your honest broker
      • 06:40to know.
      • 06:41We know who they are
      • 06:42to collect the data, but
      • 06:43you are not getting anything.
      • 06:45And, again, some of the
      • 06:46other things that we've done
      • 06:48is collecting films,
      • 06:49radiology scans. So we work
      • 06:51with investigators.
      • 06:53If they wanna collect anything,
      • 06:55we we can help you
      • 06:57and and kinda brainstorm how
      • 06:58to do this.
      • 06:59Next slide.
      • 07:01So this is just a
      • 07:03really quick example of the
      • 07:05studies that we've done.
      • 07:08So prospective identification
      • 07:10with surveys and pathology collections.
      • 07:12These, again, newly diagnosed.
      • 07:15We do you know, I've
      • 07:17talked a little bit about
      • 07:18this where we can,
      • 07:20we can consent the patient.
      • 07:22We can collect,
      • 07:23some a survey. We can
      • 07:25collect their specimens.
      • 07:28We do this, again, also
      • 07:29retrospectively.
      • 07:30Like, there's a a retrospective
      • 07:32cohort of ten years of,
      • 07:34let's say,
      • 07:36brain tumors,
      • 07:38and we can go back
      • 07:39and do a whole medical
      • 07:40record abstraction, collect their slide
      • 07:42their blocks,
      • 07:44collect imaging, everything.
      • 07:47Number three is, again, our
      • 07:48our work with our connect
      • 07:50with the Connecticut Tumor Registry.
      • 07:51This is like our our
      • 07:53kinda Connecticut Tumor Registry hat
      • 07:55a little bit differently than
      • 07:56as working as a Yale
      • 07:58employee.
      • 08:00And we we can collect,
      • 08:02specimens, medical record abstraction
      • 08:06for,
      • 08:07any, you know, any patient
      • 08:09diagnosed in Connecticut.
      • 08:11As you know,
      • 08:12any cancer diagnosis is reportable
      • 08:15to the Connecticut Tumor Registry,
      • 08:16so they
      • 08:18have everybody who's been diagnosed
      • 08:20with cancer. It's the oldest,
      • 08:22tumor registry in the country.
      • 08:25And then, again, our, like
      • 08:27I've said before, we also
      • 08:28can collect,
      • 08:30blood, stools. We've done some
      • 08:31of these,
      • 08:33CSF collections that investigators need.
      • 08:35We we bring the tubes,
      • 08:37and then when they're getting
      • 08:38their CSF or their biopsy,
      • 08:40we then,
      • 08:41transport that back to the
      • 08:43lab that's gonna be,
      • 08:46analyzing that.
      • 08:48Next slide.
      • 08:51So just I've touched a
      • 08:52little bit about this, but
      • 08:53the benefits
      • 08:54is that we we have
      • 08:57a lot of experience.
      • 08:59I've been this I've been
      • 09:00doing this for twenty five
      • 09:01years in this position. We
      • 09:03have Rocco who's been here
      • 09:04for thirty five years, forty
      • 09:06years.
      • 09:08So we we've have a
      • 09:10lot of experience in in
      • 09:12lab experience
      • 09:13and IRB experience. We're very
      • 09:15flexible.
      • 09:17I usually meet with every
      • 09:19investigator that wants to use
      • 09:21RCA just to kinda guide
      • 09:22them. You don't have to
      • 09:23use me. A lot of
      • 09:24times, they're like, oh, thank
      • 09:25you for letting me know
      • 09:26I could do this. So
      • 09:27I'm here just for to
      • 09:29also provide guidance,
      • 09:30through study planning,
      • 09:33just to give you just,
      • 09:35ideas and how to better
      • 09:37do your study. If you
      • 09:38don't have any funding, I've
      • 09:39still I can still help
      • 09:40you. You know, I'm happy
      • 09:41to meet with anybody
      • 09:43just to guide you on
      • 09:44what you need to do.
      • 09:45I do this all the
      • 09:46time. How do I apply
      • 09:47for IRB?
      • 09:49So I'm here to, you
      • 09:50know, support anybody here at
      • 09:52the cancer center.
      • 09:54Next slide.
      • 09:56So here's my email.
      • 09:58Please feel free to reach
      • 09:59out,
      • 10:01and I can, you know,
      • 10:02try to help you in
      • 10:03any way I can.